Bradsher Neal C Insider Trades

Insider Trading History

Track insider trading activity for Bradsher Neal C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $153k 125,000 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 125,000 shares
$1.30
$1.22
Staar Surgical
Staar Surgical STAA
10% owner
Holding Value $305k 11,145 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$325k 11,145 shares
$29.12
$27.34
Staar Surgical
Staar Surgical STAA
10% owner
Holding Value $206k 7,524 shares
Last Trade
Mar 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 7,524 shares
$18.46
$27.34
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $91.5k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $91.5k 75,000 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.3k 75,000 shares
$0.95
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $61k 50,000 shares
Last Trade
Jul 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.5k 50,000 shares
$1.41
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $61k 50,000 shares
Last Trade
Jul 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.5k 50,000 shares
$1.57
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $61k 50,000 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 50,000 shares
$2.86
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $0 0 shares
Last Trade
Jun 25, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$70.2k 24,720 shares
$2.84
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $107k 87,628 shares
Last Trade
Jun 25, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$70.2k 24,720 shares
$2.84
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $48.8k 40,000 shares
Last Trade
Jul 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.2k 40,000 shares
$0.83
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $48.8k 40,000 shares
Last Trade
Jul 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.2k 40,000 shares
$1.03
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $48.8k 40,000 shares
Last Trade
Jul 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.4k 40,000 shares
$2.06
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $24.4k 20,000 shares
Last Trade
Jul 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63k 20,000 shares
$3.15
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $24.4k 20,000 shares
Last Trade
Jul 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.4k 20,000 shares
$2.72
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $24.4k 20,000 shares
Last Trade
Jul 01, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.7k 20,000 shares
$3.08
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $24.4k 20,000 shares
Last Trade
Jul 01, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.7k 20,000 shares
$2.69
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $76.7k 62,908 shares
Last Trade
Jun 30, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.7k 20,000 shares
$2.63
$1.22
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
10% owner
Holding Value $0 0 shares
Last Trade
Jun 30, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.7k 20,000 shares
$2.63
$1.22
Eterna Therapeutics
Eterna Therapeutics ERNA
10% owner
Holding Value $56.5M 9,322,262 shares
Last Trade
Dec 30, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.41B 175,000 shares
$19,500.00
$6.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up